TickerFacts.

Medline Inc. (MDLN): Operating Cash Flow

Annual figures by period end, from SEC filings.

$1.74B
Year ended 2025-12-31
$1.99B
Trailing 12 months to 2026-06-27
$1.77B2023-12-31: $1.69B2024-12-31: $1.77B2025-12-31: $1.74B$1.74B
2023-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$1.74B-1.4%2026-02-25, From 2025-01-01
2024-12-31$1.77B+5.0%2026-02-25, From 2024-01-01
2023-12-31$1.69Bn/a2026-02-25, From 2023-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Medline Inc. (MDLN)2025-12-31$1.74B-1.4%
Stryker Corp (SYK)2025-12-31$5.04B+18.9%
3M Co (MMM)2025-12-31$2.31B+26.8%
Becton Dickinson & Co (BDX)2025-09-30$3.43B-10.8%
Boston Scientific Corp (BSX)2025-12-31$4.53B+32.0%
Baxter International Inc (BAX)2025-12-31$845.00M-17.1%
Solventum Corp (SOLV)2025-12-31$369.00M-68.9%
ResMed Inc (RMD)2026-06-30$1.81B+3.1%
Dexcom Inc (DXCM)2025-12-31$1.44B+45.6%

Compare MDLN, SYK, MMM, BDX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗